Surrey, Canada

David B Fenske


Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 232(Granted Patents)


Company Filing History:


Years Active: 1998-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: David B Fenske: Innovator in Lipid-Based Drug Delivery Systems

Introduction

David B Fenske is a prominent inventor based in Surrey, Canada. He has made significant contributions to the field of lipid-based drug delivery systems, holding a total of 4 patents. His work focuses on enhancing cellular uptake and improving the delivery of nucleic acids through innovative methods.

Latest Patents

Fenske's latest patents include "Cationic peg-lipids and methods of use." This invention provides cationic-polymer-lipid conjugates (CPLs) that can be incorporated into conventional and stealth liposomes or other lipid-based formulations to enhance cellular uptake. The CPLs consist of a lipid moiety, a hydrophilic polymer, and a polycationic moiety. Additionally, he has developed methods for increasing intracellular delivery of nucleic acids.

Another notable patent is "Ionophore-mediated liposome loading." This patent presents novel methods for loading a weakly basic drug into liposomes using an electoneutral transport system. In these methods, ionophores are utilized with liposomes that have a metal ion gradient to facilitate the exchange of metal ions for protons. The transported metal ion may be complexed with a chelating agent present in the external media.

Career Highlights

David B Fenske is affiliated with the University of British Columbia, where he continues to advance research in drug delivery systems. His innovative approaches have garnered attention in the scientific community, contributing to the development of more effective therapeutic strategies.

Collaborations

Fenske has collaborated with notable colleagues, including Pieter Rutter Cullis and Kim F Wong. These partnerships have further enriched his research and expanded the impact of his inventions.

Conclusion

David B Fenske is a key figure in the field of lipid-based drug delivery, with a focus on enhancing cellular uptake and nucleic acid delivery. His contributions through innovative patents and collaborations continue to shape advancements in this important area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…